Prospective validation of single mouse testing by the paediatric preclinical testing consortium

Bookmark and Share
Published: 4 Nov 2020
Views: 102
Rating:
Save
Dr Peter Houghton - Greehey Children's Cancer Institute, San Antonio, USA

Dr Peter Houghton speaks to ecancer about the prospective validation of single mouse testing by the paediatric preclinical testing consortium; a study that was presented at ENA 2020 this year.

Dr Houghton initially explains the rationale behind this study and talks about how it was tested that using a single mouse for studying drug efficacy in paediatric cancers can give the same results as using more mice.

He considers it to be a great scientific break through that can change how pre-clinical testing is done currently. He then speaks of the key results obtained form this study and how it can impact the future.